Ozempic could be the next target of Medicare drug price negotiations – here’s why
Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on...
Currencies: The U.S. dollar strikes back: What’s next after August rally
The U.S. dollar bounces back strongly in August. Can it build on the momentum?
: AMC’s stock gets a Taylor Swift boost as Eras Tour movie tickets go on sale
AMC's stock rose after the announcement that a Taylor Swift movie is coming to theaters in October.
Market Extra: What August’s jobs report could mean for stocks
Economists expect job gains to slow to 170,000 in August and an actual number below that estimate has the potential to buttress the argument for...
Living With Climate Change: Hurricane Idalia: Florida storm is 2023’s costliest U.S. disaster so far
As climate change creates warm-water 'fuel' for hurricanes like Idalia, insurance gets costlier and economic damage can be greater.
: Trump doubles down on call for ‘simple but powerful tariff’ that has been slammed by economists
Donald Trump is arguing for his tariff policy in a letter to the Wall Street Journal, calling levies "an important tool of U.S. national security"...
The Ratings Game: Palantir’s stock sinks after downgrade, with half of Wall Street analysts now bearish
Within the Russell 1000, only 10 stocks are rated at the equivalent of "sell" by at least 50% of analysts, and now Palantir is one...
Economic Report: Mortgage rates retreat from multidecade highs, but still remain volatile, Freddie Mac says
The U.S. 30-year mortgage rate is averaging at 7.18%, Freddie Mac said in its latest weekly survey on Thursday.
The Big Move: In 1999, I bought a rental house in California for $270,000. It’s now worth $1.3 million. Should I sell it, and put the money in CDs?
'We're earning $8,000 per month from long-term tenants.'